Reports are emerging about unusual medical practices and advancements in treating rare diseases. Some outlets are highlighting the use of new technologies, such as ai, and gene-editing strategies to develop new treatments, while others are discussing market access programs and health equity for affected communities. The topic appears to be part of a broader discussion that also touches on historical medical missteps and unique cultural practices, although the exact connections between these themes are unclear.